EU5 Cardiovascular Monitoring Devices Market Outlook to 2033 – Resting ECG Machines and Holter Monitors

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: February 20, 2026 Report Code: GDME21652CRDB-ST

Select Item

GlobalData’s “EU5 Cardiovascular Monitoring Devices Outlook to 2033” is a comprehensive databook report, covering key market data on the EU5 Cardiovascular Monitoring Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Resting ECG Machines and Holter Monitoring Systems

The EU5 Cardiovascular Monitoring Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Cardiovascular Monitoring Devices Market.
• Global corporate-level profiles of key companies operating within the EU5 Cardiovascular Monitoring Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Cardiovascular Monitoring Devices is segmented as follows:_x000D_

• Resting ECG Machines_x000D_

• Holter Monitoring Systems

Reasons to Buy

The EU5 Cardiovascular Monitoring Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Cardiovascular Monitoring Devices Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Cardiovascular Monitoring Devices Market, EU5

3.1 Cardiovascular Monitoring Devices Market, EU5, Revenue ($m), 2018-2033

3.2 Cardiovascular Monitoring Devices Market, EU5, Revenue ($m), 2018-2033

3.3 Cardiovascular Monitoring Devices Market, EU5, Volume (Units), 2018-2033

3.4 Cardiovascular Monitoring Devices Market, EU5, Volume (Units), 2018-2033

3.5 Cardiovascular Monitoring Devices Market, EU5, Company Share by Revenue ($m), 2024

4 Cardiovascular Monitoring Devices Market, France

4.1 Cardiovascular Monitoring Devices Market, France, Revenue ($m), 2018-2033

4.1.1 Holter Monitors Market, France, Revenue ($m), by Segment, 2018-2033

4.2 Cardiovascular Monitoring Devices Market, France, Volume (Units), 2018-2033

4.2.1 Holter Monitors Market, France, Volume (Units), by Segment, 2018-2033

4.3 Cardiovascular Monitoring Devices Market, France, Average Price ($), 2018-2033

4.4 Cardiovascular Monitoring Devices Market, France, Company Share by Revenue ($m), 2024

5 Cardiovascular Monitoring Devices Market, Germany

5.1 Cardiovascular Monitoring Devices Market, Germany, Revenue ($m), 2018-2033

5.1.1 Holter Monitors Market, Germany, Revenue ($m), by Segment, 2018-2033

5.2 Cardiovascular Monitoring Devices Market, Germany, Volume (Units), 2018-2033

5.2.1 Holter Monitors Market, Germany, Volume (Units), by Segment, 2018-2033

5.3 Cardiovascular Monitoring Devices Market, Germany, Average Price ($), 2018-2033

5.4 Cardiovascular Monitoring Devices Market, Germany, Company Share by Revenue ($m), 2024

6 Cardiovascular Monitoring Devices Market, Italy

6.1 Cardiovascular Monitoring Devices Market, Italy, Revenue ($m), 2018-2033

6.1.1 Holter Monitors Market, Italy, Revenue ($m), by Segment, 2018-2033

6.2 Cardiovascular Monitoring Devices Market, Italy, Volume (Units), 2018-2033

6.2.1 Holter Monitors Market, Italy, Volume (Units), by Segment, 2018-2033

6.3 Cardiovascular Monitoring Devices Market, Italy, Average Price ($), 2018-2033

6.4 Cardiovascular Monitoring Devices Market, Italy, Company Share by Revenue ($m), 2024

7 Cardiovascular Monitoring Devices Market, Spain

7.1 Cardiovascular Monitoring Devices Market, Spain, Revenue ($m), 2018-2033

7.1.1 Holter Monitors Market, Spain, Revenue ($m), by Segment, 2018-2033

7.2 Cardiovascular Monitoring Devices Market, Spain, Volume (Units), 2018-2033

7.2.1 Holter Monitors Market, Spain, Volume (Units), by Segment, 2018-2033

7.3 Cardiovascular Monitoring Devices Market, Spain, Average Price ($), 2018-2033

7.4 Cardiovascular Monitoring Devices Market, Spain, Company Share by Revenue ($m), 2024

8 Cardiovascular Monitoring Devices Market, United Kingdom

8.1 Cardiovascular Monitoring Devices Market, United Kingdom, Revenue ($m), 2018-2033

8.1.1 Holter Monitors Market, United Kingdom, Revenue ($m), by Segment, 2018-2033

8.2 Cardiovascular Monitoring Devices Market, United Kingdom, Volume (Units), 2018-2033

8.2.1 Holter Monitors Market, United Kingdom, Volume (Units), by Segment, 2018-2033

8.3 Cardiovascular Monitoring Devices Market, United Kingdom, Average Price ($), 2018-2033

8.4 Cardiovascular Monitoring Devices Market, United Kingdom, Company Share by Revenue ($m), 2024

9 Overview of Key Companies in EU5 Cardiovascular Monitoring Devices Market

9.1 Koninklijke Philips NV

9.1.1 Company Overview

9.2 Boston Scientific Corp

9.2.1 Company Overview

9.3 Suzuken Co Ltd

9.3.1 Company Overview

9.4 GE HealthCare Technologies Inc

9.4.1 Company Overview

9.5 Contec Medical Systems Co Ltd

9.5.1 Company Overview

9.6 Hill-Rom Holdings Inc

9.6.1 Company Overview

9.7 Shenzhen Mindray Bio-Medical Electronics Co Ltd

9.7.1 Company Overview

10 Cardiovascular Monitoring Devices Market Pipeline Products

11 Recent Developments

11.1 Corporate Communications

11.1.1 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment

11.1.2 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem

11.1.3 Nov 04, 2025: Philips Q3 2025 Results: CEO Roy Jakobs on CNBC

11.1.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

11.1.5 Oct 13, 2025: To_aition Project Reveals Links Between Cardiovascular Disease And Mental Health

11.1.6 Oct 06, 2025: Acorai Reports Positive CAPTURE-HF Study Results for Its AI-Powered Heart Failure Management Device

11.1.7 Oct 04, 2025: Coloplast Interim CEO Lars Rasmussen Steps Down From Board At Upcoming Annual General Meeting

11.1.8 Oct 01, 2025: Philips Appoints Stephanie Sievers As Managing Director For Philips APAC

11.1.9 Sep 26, 2025: Innovations of Hemolens Diagnostics in Non-Invasive Heart Diagnostics

11.1.10 Sep 22, 2025: Introducing The Ideall Roadmap – Edi Principles For Turning Lost Carbon Into A Valuable Resource

11.1.11 Sep 17, 2025: Southlake Health Transforms Diagnostic Imaging with Philips AI-Enabled MRI

11.1.12 Sep 10, 2025: Biotronik Launches Solia CSP S To Simplify Conduction System Pacing Procedures

11.1.13 Sep 08, 2025: Immunotherapy Before Surgery Shows Promise for Rare Lung Cancer Treatment

11.1.14 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors

11.1.15 Jul 18, 2025: PARP has awarded Medicalgorithmics PLN

9.4 million in funding New product to be developed based on the certified VCAST technology

11.1.16 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

11.1.17 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

11.2 Financial Announcements

11.2.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

11.2.2 Nov 06, 2025: Acarix AB Publishes Third Quarter 2025 Results

11.2.3 Nov 04, 2025: Philips Q3 2025 Results: CEO Roy Jakobs on CNBC

11.2.4 Oct 20, 2025: Coloplast A/S: Invitation for Conference Call on 4 Nov 2025 at

11.00 CET

11.2.5 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results

11.2.6 Aug 08, 2025: Coloplast A/S – 9M 2024/25 Earnings Release – Invitation to Conference Call on 19 August 2025 at

11.00am CEST

11.2.7 Jul 02, 2025: Medicalgorithmics enters a period of dynamic growth – Q2 revenues up

17.6% Year-over-Year, driven by a 136% increase in AI-based software sales in the U.S.

11.2.8 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025

11.3 Government and Public Interest

11.3.1 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences

11.3.2 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference

11.4 Legal And Regulatory

11.4.1 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market

11.5 Other Significant Developments

11.5.1 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment

11.5.2 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

11.5.3 Nov 06, 2025: Acarix AB Publishes Third Quarter 2025 Results

11.5.4 Nov 04, 2025: Adrz Offers Shorter Echocardiograms for Heart Monitoring

11.5.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

11.5.6 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market

11.5.7 Oct 17, 2025: New Value Based Procurement Guidelines Launched

11.5.8 Sep 23, 2025: American Medical Association Publishes CPT Code for Caristo's Coronary Inflammation Detection Technology

11.5.9 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death

11.5.10 Jul 07, 2025: New contract in Belgium with Byteflies – Medicalgorithmics achieves record number of AI-powered diagnostic agreements

11.5.11 Jun 02, 2025: Successful Q1 for Medicalgorithmics.Service revenue in the U.S. up 329% YoY. 11 new contracts in the first five months of

2025.

11.5.12 Mar 04, 2025: Medicalgorithmics enters the Turkish market with an annual potential of PLN

1.5 Million

11.5.13 Nov 30, 2024: Medicalgorithmics Consistently Executes Its Strategy and Expands Service Sales

11.6 Product News

11.6.1 Nov 20, 2025: Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Clinical Results

11.6.2 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment

11.6.3 Nov 05, 2025: Fluid Control Solutions For MedTech

11.6.4 Oct 28, 2025: Medicalgorithmics And Lund University Collaborate On AI Initiative For Cardiac Function Dataset

11.6.5 Oct 22, 2025: Norav Medical Launches TeleEVENT – Full Disclosure Event Recorder for Remote Cardiac Telemetry

11.6.6 Oct 13, 2025: To_aition Project Reveals Links Between Cardiovascular Disease And Mental Health

11.6.7 Oct 06, 2025: Acorai Reports Positive CAPTURE-HF Study Results for Its AI-Powered Heart Failure Management Device

11.6.8 Sep 30, 2025: Relief Cardiovascular Announces First-In-Human Procedures With Transcatheter Smart Implant for Heart Failure Treatment

11.6.9 Sep 28, 2025: Acoramidis Reduces Cardiovascular Outcomes in ATTR-CM Patients Within the First Month

11.6.10 Sep 26, 2025: Innovations of Hemolens Diagnostics in Non-Invasive Heart Diagnostics

11.6.11 Sep 23, 2025: American Medical Association Publishes CPT Code for Caristo's Coronary Inflammation Detection Technology

11.6.12 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial

11.6.13 Sep 15, 2025: Visualization of Blood Flow Improves Artificial Heart Design

11.6.14 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death

11.6.15 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection

11.7 Strategy And Business Planning

11.7.1 Nov 20, 2025: New Propelus Prototype Centers

11.7.2 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem

11.7.3 Nov 06, 2025: Acarix AB Publishes Third Quarter 2025 Results

11.7.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

11.7.5 Oct 28, 2025: Medicalgorithmics And Lund University Collaborate On AI Initiative For Cardiac Function Dataset

11.7.6 Oct 16, 2025: Building Work on National MRI Facility Begins at University of Nottingham

11.7.7 Oct 07, 2025: Physiotika Announces Partnership With IonOptix in France

11.7.8 Sep 26, 2025: Philips and Optum to expand cardiac monitoring services in US

11.7.9 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider

11.7.10 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial

11.7.11 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection

11.7.12 Jul 29, 2025: Medicalgorithmics Inks Commercial Agreement With NexGen MediQ

11.7.13 Jul 08, 2025: Acarix Enters MENA Region with First Major Order, Expanding Global Presence

12 Appendix

12.1 Research Methodology

12.1.1 Coverage

12.1.2 Secondary Research

12.1.3 Primary Research

12.1.4 Market Modeling and Forecasting

12.1.5 Company Share Analysis

12.1.6 Benchmarking

12.2 GlobalData Consulting

12.3 Contact Us

12.4 Disclaimer

Table

Table 1: Cardiovascular Monitoring Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033

Table 2: Cardiovascular Monitoring Devices Market, EU5, Revenue ($m), USD Constant, 2018-2033

Table 3: Cardiovascular Monitoring Devices Market, EU5, Volume (Units), 2018-2033

Table 4: Cardiovascular Monitoring Devices Market, EU5, Volume (Units), 2018-2033

Table 5: Cardiovascular Monitoring Devices Market, EU5, Company Share by Revenue ($m), 2024

Table 6: Cardiovascular Monitoring Devices Market, France, Revenue ($m), USD Constant, 2018-2033

Table 7: Holter Monitors Market, France, Revenue ($m), USD Constant, 2018-2033

Table 8: Cardiovascular Monitoring Devices Market, France, Volume (Units), 2018-2033

Table 9: Holter Monitors Market, France, Volume (Units), 2018-2033

Table 10: Cardiovascular Monitoring Devices Market, France, Average Price ($), 2018-2033

Table 11: Cardiovascular Monitoring Devices Market, France, Company Share by Revenue ($m), 2024

Table 12: Cardiovascular Monitoring Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033

Table 13: Holter Monitors Market, Germany, Revenue ($m), USD Constant, 2018-2033

Table 14: Cardiovascular Monitoring Devices Market, Germany, Volume (Units), 2018-2033

Table 15: Holter Monitors Market, Germany, Volume (Units), 2018-2033

Table 16: Cardiovascular Monitoring Devices Market, Germany, Average Price ($), 2018-2033

Table 17: Cardiovascular Monitoring Devices Market, Germany, Company Share by Revenue ($m), 2024

Table 18: Cardiovascular Monitoring Devices Market, Italy, Revenue ($m), USD Constant, 2018-2033

Table 19: Holter Monitors Market, Italy, Revenue ($m), USD Constant, 2018-2033

Table 20: Cardiovascular Monitoring Devices Market, Italy, Volume (Units), 2018-2033

Table 21: Holter Monitors Market, Italy, Volume (Units), 2018-2033

Table 22: Cardiovascular Monitoring Devices Market, Italy, Average Price ($), 2018-2033

Table 23: Cardiovascular Monitoring Devices Market, Italy, Company Share by Revenue ($m), 2024

Table 24: Cardiovascular Monitoring Devices Market, Spain, Revenue ($m), USD Constant, 2018-2033

Table 25: Holter Monitors Market, Spain, Revenue ($m), USD Constant, 2018-2033

Table 26: Cardiovascular Monitoring Devices Market, Spain, Volume (Units), 2018-2033

Table 27: Holter Monitors Market, Spain, Volume (Units), 2018-2033

Table 28: Cardiovascular Monitoring Devices Market, Spain, Average Price ($), 2018-2033

Table 29: Cardiovascular Monitoring Devices Market, Spain, Company Share by Revenue ($m), 2024

Table 30: Cardiovascular Monitoring Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Table 31: Holter Monitors Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Table 32: Cardiovascular Monitoring Devices Market, United Kingdom, Volume (Units), 2018-2033

Table 33: Holter Monitors Market, United Kingdom, Volume (Units), 2018-2033

Table 34: Cardiovascular Monitoring Devices Market, United Kingdom, Average Price ($), 2018-2033

Table 35: Cardiovascular Monitoring Devices Market, United Kingdom, Company Share by Revenue ($m), 2024

Table 36: Cardiovascular Monitoring Devices Market Pipeline Products

Figures

Figure 1: Cardiovascular Monitoring Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033

Figure 2: Cardiovascular Monitoring Devices Market, EU5, Revenue ($m), USD Constant, 2018-2033

Figure 3: Cardiovascular Monitoring Devices Market, EU5, Volume (Units), 2018-2033

Figure 4: Cardiovascular Monitoring Devices Market, EU5, Volume (Units), 2018-2033

Figure 5: Cardiovascular Monitoring Devices Market, EU5, Company Share (%), 2024

Figure 6: Cardiovascular Monitoring Devices Market, France, Revenue ($m), USD Constant, 2018-2033

Figure 7: Holter Monitors Market, France, Revenue ($m), USD Constant, 2018-2033

Figure 8: Cardiovascular Monitoring Devices Market, France, Volume (Units), 2018-2033

Figure 9: Holter Monitors Market, France, Volume (Units), 2018-2033

Figure 10: Cardiovascular Monitoring Devices Market, France, Company Share (%), 2024

Figure 11: Cardiovascular Monitoring Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033

Figure 12: Holter Monitors Market, Germany, Revenue ($m), USD Constant, 2018-2033

Figure 13: Cardiovascular Monitoring Devices Market, Germany, Volume (Units), 2018-2033

Figure 14: Holter Monitors Market, Germany, Volume (Units), 2018-2033

Figure 15: Cardiovascular Monitoring Devices Market, Germany, Company Share (%), 2024

Figure 16: Cardiovascular Monitoring Devices Market, Italy, Revenue ($m), USD Constant, 2018-2033

Figure 17: Holter Monitors Market, Italy, Revenue ($m), USD Constant, 2018-2033

Figure 18: Cardiovascular Monitoring Devices Market, Italy, Volume (Units), 2018-2033

Figure 19: Holter Monitors Market, Italy, Volume (Units), 2018-2033

Figure 20: Cardiovascular Monitoring Devices Market, Italy, Company Share (%), 2024

Figure 21: Cardiovascular Monitoring Devices Market, Spain, Revenue ($m), USD Constant, 2018-2033

Figure 22: Holter Monitors Market, Spain, Revenue ($m), USD Constant, 2018-2033

Figure 23: Cardiovascular Monitoring Devices Market, Spain, Volume (Units), 2018-2033

Figure 24: Holter Monitors Market, Spain, Volume (Units), 2018-2033

Figure 25: Cardiovascular Monitoring Devices Market, Spain, Company Share (%), 2024

Figure 26: Cardiovascular Monitoring Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Figure 27: Holter Monitors Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Figure 28: Cardiovascular Monitoring Devices Market, United Kingdom, Volume (Units), 2018-2033

Figure 29: Holter Monitors Market, United Kingdom, Volume (Units), 2018-2033

Figure 30: Cardiovascular Monitoring Devices Market, United Kingdom, Company Share (%), 2024

EU5 Cardiovascular Monitoring Devices Market Outlook to 2033 – Resting ECG Machines and Holter Monitors standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Patient Monitoring reports
Medical Devices
New
Adult Feeding Tubes and Formula Market Size by Segments, Share,…
$7,500 | October 2026
Medical Devices
New
Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | October 2026
Medical Devices
New
Body Contouring Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | October 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at EU5 Cardiovascular Monitoring Devices Market Outlook to 2033 – Resting ECG Machines and Holter Monitors in real time.

  • Access a live EU5 Cardiovascular Monitoring Devices Market Outlook to 2033 – Resting ECG Machines and Holter Monitors dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more